Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says
Go back to Johnson & Johnson to stay out of obesity drugs, focus on cancer, CEO says| Johnson & Johnson (NYSE: JNJ) | Delayed: 270.22 +2.94 (1.10%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $267.28 | 52 Week High | $126.07 | |||
| Open | $268.00 | 52 Week Low | $94.28 | |||
| Day High | $270.87 | P/E | 56.18 | |||
| Day Low | $267.11 | EPS | $4.81 | |||
| Volume | 6,572,276 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 147.15 +2.24 (1.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $144.91 | 52 Week High | $65.46 | |||
| Open | $145.74 | 52 Week Low | $47.97 | |||
| Day High | $147.65 | P/E | 100.10 | |||
| Day Low | $145.32 | EPS | $1.47 | |||
| Volume | 11,063,719 | |||||
| NOVO-NORDISK A/S (NYSE: NVO) | Delayed: 43.19 +1.48 (3.55%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $41.71 | 52 Week High | $59.00 | |||
| Open | $41.98 | 52 Week Low | $32.80 | |||
| Day High | $43.44 | P/E | N/A | |||
| Day Low | $41.96 | EPS | $0.00 | |||
| Volume | 12,974,379 | |||||
